Financial Growth

Exact Sciences delivered over 4.6 million cancer test results in 2024, showcasing significant growth and innovation in cancer diagnostics. Key achievements include FDA approval for Cologuard Plus and the introduction of Oncodetect, enhancing colon cancer screening and molecular residual disease detection. The